Antibody recognizing N-domain of midkine
Abstract:
The present disclosure relates to isolated or recombinant proteins, such as antibodies, which inhibit or reduce the function of midkine (hereinafter, referred to as “MK”) for use in the treatment or prevention of midkine-related disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0